PHAR earnings date and last-quarter result: next report 2026-07-30, last quarter miss, P/E 65.66. Updated 2026-07-23.
Pharming Group (PHAR) Research Hub
Pharming Group (PHAR) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 11.9 USD (+6.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 65.66, market cap 0.94B. This hub links to the full technical, earnings and options research available for PHAR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 11.9 USD (+6.25%) |
| 52-week range | 9.11 USD – 14.5 USD |
| Trend regime | Range |
| 14-day RSI | 74.8 (Overbought) |
| Trailing P/E | 65.66 |
| Market cap | 0.94B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for PHAR
Covered Call on PHAR: how it works, illustrative setup around the real 11.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PHAR: how it works, illustrative setup around the real 11.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PHAR: how it works, illustrative setup around the real 11.9 USD price, max profit/loss, breakeven and when to use it. Educational.
PHAR technical analysis: range, last 11.9 USD, RSI 74.8, 52w range 9.11 USD–14.5 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PHAR in?
Pharming Group (PHAR) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is PHAR in an uptrend or downtrend?
As of 2026-10-26, PHAR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PHAR's trailing P/E ratio?
PHAR's trailing P/E is 65.66, with a market cap of 0.94B. See the earnings research page for full valuation detail.
When does PHAR next report earnings?
PHAR is next scheduled to report earnings on 2026-07-30.